Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
facilities
Biotech
AstraZeneca vows $15B China investment to boost R&D capabilities
AstraZeneca made a broad commitment to China to enhance its capabilities in areas including cell therapies and radioconjugates.
Nick Paul Taylor
Jan 29, 2026 5:50am
AstraZeneca details $2.5B investment in China's political center
Mar 21, 2025 8:35am
Mission changes, shuttering lab to focus on clinical assets
Feb 28, 2025 6:40am
AmplifyBio shutters Bay Area site, lays off Ohio CRO staff
Dec 6, 2024 11:31am
NSF grants $22M for extreme microbe research hub
Aug 30, 2024 11:55am
Worldwide Clinical gains accreditation from pathologists group
Sep 21, 2023 10:05am
